Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 256

    1.

    Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy.

    Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD.

    J Am Soc Nephrol. 2009 Nov 19. [Epub ahead of print]PMID: 19926893 [PubMed - as supplied by publisher]Related articles

    2.

    Review of clinical trials: update on oral insulin spray formulation.

    Pozzilli P, Raskin P, Parkin CG.

    Diabetes Obes Metab. 2009 Nov 2. [Epub ahead of print]PMID: 19889002 [PubMed - as supplied by publisher]Related articles

    3.

    Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?

    Lingvay I, Legendre JL, Kaloyanova PF, Zhang S, Adams-Huet B, Raskin P.

    Diabetes Care. 2009 Oct;32(10):1789-95. Epub 2009 Jul 10.PMID: 19592630 [PubMed - in process]Related articles

    4.

    Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes.

    Raskin P, Gylvin T, Weng W, Chaykin L.

    Diabetes Metab Res Rev. 2009 Sep;25(6):542-8.PMID: 19565569 [PubMed - in process]Related articles

    5.

    Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control.

    Raskin P, Lewin A, Reinhardt R, Lyness W; Repaglinide/Metformin Fixed-Dose Combination Study Group.

    Diabetes Obes Metab. 2009 Oct;11(10):947-52. Epub 2009 Jun 16.PMID: 19531054 [PubMed - in process]Related articles

    6.

    Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.

    Blonde L, Merilainen M, Karwe V, Raskin P; TITRATE Study Group.

    Diabetes Obes Metab. 2009 Jun;11(6):623-31.PMID: 19515182 [PubMed - in process]Related articles

    7.

    Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet.

    Raskin P, Lewin A, Reinhardt R, Lyness W; Repaglinide/Metformin Fixed-Dose Combination Study Group.

    Diabetes Obes Metab. 2009 Sep;11(9):865-73. Epub 2009 May 19.PMID: 19476470 [PubMed - in process]Related articles

    8.

    Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review.

    Fordan S, Raskin P.

    Vasc Health Risk Manag. 2009;5(1):225-31. Epub 2009 Apr 8. Review.PMID: 19436644 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The fatty hearts of patients with diabetes.

    Lingvay I, Raskin P, Szczepaniak LS.

    Nat Rev Cardiol. 2009 Apr;6(4):268-9.PMID: 19352328 [PubMed - indexed for MEDLINE]Related articles

    10.

    Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).

    Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L; LEAD-4 Study Investigators.

    Diabetes Care. 2009 Jul;32(7):1224-30. Epub 2009 Mar 16.PMID: 19289857 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.

    Phillips RA, Fonseca V, Katholi RE, McGill JB, Messerli FH, Bell DS, Raskin P, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Bakris GL; GEMINI Investigators.

    J Cardiometab Syndr. 2008 Fall;3(4):211-7.PMID: 19040589 [PubMed - indexed for MEDLINE]Related articles

    12.

    Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.

    Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P.

    Anesthesiology. 2008 Jul;109(1):14-24.PMID: 18580168 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.

    Raskin P.

    Diabetes Obes Metab. 2008 Dec;10(12):1167-77. Epub 2008 May 20. Review.PMID: 18494804 [PubMed - indexed for MEDLINE]Related articles

    14.

    Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy.

    Chance WW, Rhee C, Yilmaz C, Dane DM, Pruneda ML, Raskin P, Hsia CC.

    Diabetes Care. 2008 Aug;31(8):1596-601. Epub 2008 May 20.PMID: 18492945 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Lung involvement in diabetes: does it matter?

    Hsia CC, Raskin P.

    Diabetes Care. 2008 Apr;31(4):828-9. No abstract available. PMID: 18375433 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.

    Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P; American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.

    Circulation. 2008 Mar 25;117(12):1610-9. Epub 2008 Feb 25.PMID: 18299505 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.

    Wright JT Jr, Bakris GL, Bell DS, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Holdbrook FK, Lukas MA, Iyengar M.

    J Clin Hypertens (Greenwich). 2007 Nov;9(11):842-9.PMID: 17978591 [PubMed - indexed for MEDLINE]Related articles

    19.

    Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes.

    Raskin P.

    Diabetes Metab Res Rev. 2008 Jan-Feb;24(1):3-13. Review.PMID: 17968971 [PubMed - indexed for MEDLINE]Related articles

    20.

    Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).

    Raskin P, Matfin G, Schwartz SL, Chaykin L, Chu PL, Braceras R, Wynne A.

    Diabetes Obes Metab. 2009 Jan;11(1):27-32. Epub 2007 Oct 17.PMID: 17941873 [PubMed - indexed for MEDLINE]Related articles

    21.

    Efficacy and safety of insulin detemir.

    Raskin P.

    Endocrinol Metab Clin North Am. 2007 Aug;36 Suppl 1:21-32. Review.PMID: 17881329 [PubMed - indexed for MEDLINE]Related articles

    22.

    Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes.

    Zib I, Jacob AN, Lingvay I, Salinas K, McGavock JM, Raskin P, Szczepaniak LS.

    J Investig Med. 2007 Jul;55(5):230-6.PMID: 17850734 [PubMed - indexed for MEDLINE]Related articles

    23.

    Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study.

    McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS.

    Circulation. 2007 Sep 4;116(10):1170-5. Epub 2007 Aug 13.PMID: 17698735 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Lung function changes related to diabetes mellitus.

    Hsia CC, Raskin P.

    Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S73-82. Review.PMID: 17563307 [PubMed - indexed for MEDLINE]Related articles

    25.

    Body weight changes with beta-blocker use: results from GEMINI.

    Messerli FH, Bell DS, Fonseca V, Katholi RE, McGill JB, Phillips RA, Raskin P, Wright JT Jr, Bangalore S, Holdbrook FK, Lukas MA, Anderson KM, Bakris GL; GEMINI Investigators.

    Am J Med. 2007 Jul;120(7):610-5.PMID: 17602935 [PubMed - indexed for MEDLINE]Related articles

    26.

    Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes.

    Lingvay I, Raskin P, Szczepaniak LS.

    J Diabetes Complications. 2007 May-Jun;21(3):137-42.PMID: 17493545 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.

    Fonseca V, Bakris GL, Bell DS, McGill JB, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT Jr, Waterhouse B, Lukas MA, Anderson KM; for the GEMINI Investigators.

    Diabet Med. 2007 Jul;24(7):759-63. Epub 2007 Apr 19.PMID: 17451422 [PubMed - indexed for MEDLINE]Related articles

    28.

    Effects of multiple daily insulin injections on peripheral glucose disposal in Latin Americans with type 2 diabetes mellitus.

    Avilés-Santa L, Salinas K, Adams-Huet B, Raskin P.

    J Investig Med. 2007 Jan;55(1):11-7.PMID: 17441407 [PubMed - indexed for MEDLINE]Related articles

    29.

    beta-blocker use and diabetes symptom score: results from the GEMINI study.

    McGill JB, Bakris GL, Fonseca V, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Dalal MR, Bell DS.

    Diabetes Obes Metab. 2007 May;9(3):408-17.PMID: 17391169 [PubMed - indexed for MEDLINE]Related articles

    30.

    Weight gain in type 2 diabetes mellitus.

    Jacob AN, Salinas K, Adams-Huet B, Raskin P.

    Diabetes Obes Metab. 2007 May;9(3):386-93.PMID: 17391167 [PubMed - indexed for MEDLINE]Related articles

    31.

    Insulin as initial therapy in type 2 diabetes: effective, safe, and well accepted.

    Lingvay I, Kaloyanova PF, Adams-Huet B, Salinas K, Raskin P.

    J Investig Med. 2007 Mar;55(2):62-8.PMID: 17362692 [PubMed - indexed for MEDLINE]Related articles

    32.

    Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues.

    Brod M, Cobden D, Lammert M, Bushnell D, Raskin P.

    Health Qual Life Outcomes. 2007 Feb 7;5:8.PMID: 17286868 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy.

    Freeman R, Raskin P, Hewitt DJ, Vorsanger GJ, Jordan DM, Xiang J, Rosenthal NR; CAPSS-237 Study Group.

    Curr Med Res Opin. 2007 Jan;23(1):147-61.PMID: 17257476 [PubMed - indexed for MEDLINE]Related articles

    34.

    Basal insulin or premix analogue therapy in type 2 diabetes patients.

    Raskin PR, Hollander PA, Lewin A, Gabbay RA, Bode B, Garber AJ; on behalf of the INITIATE Study Group.

    Eur J Intern Med. 2007 Jan;18(1):56-62.PMID: 17223044 [PubMed - in process]Related articles

    35.

    Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US.

    Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, Raskin P, Garber A, Palmer AJ.

    Diabetes Obes Metab. 2007 Jan;9(1):103-13.PMID: 17199725 [PubMed - indexed for MEDLINE]Related articles

    36.

    The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.

    Noto H, Chitkara P, Raskin P.

    J Diabetes Complications. 2006 Nov-Dec;20(6):343-8.PMID: 17070436 [PubMed - indexed for MEDLINE]Related articles

    37.

    Novel insulin analogues and its mitogenic potential.

    Zib I, Raskin P.

    Diabetes Obes Metab. 2006 Nov;8(6):611-20. Review.PMID: 17026485 [PubMed - indexed for MEDLINE]Related articles

    38.

    Postprandial glucose and its role in type 2 diabetes.

    Diabetes Insights Editorial Board, Davidson J, Gough S, Halimi S, Liebl A, Raskin P, Yan G.

    Hormones (Athens). 2006 Jul-Sep;5(3):1 p following 217. No abstract available. PMID: 16955956 [PubMed - indexed for MEDLINE]Related articles

    39.

    The visceral and subcutaneous fat changes in type 1 diabetes: a pilot study.

    Jacob AN, Adams-Huet B, Raskin P.

    Diabetes Obes Metab. 2006 Sep;8(5):524-30.PMID: 16918587 [PubMed - indexed for MEDLINE]Related articles

    40.

    Potential causes of weight gain in type 1 diabetes mellitus.

    Jacob AN, Salinas K, Adams-Huet B, Raskin P.

    Diabetes Obes Metab. 2006 Jul;8(4):404-11. Erratum in: Diabetes Obes Metab. 2006 Jul;8(4):472. PMID: 16776747 [PubMed - indexed for MEDLINE]Related articles

    41.

    Comparison of type 1, type 2, and atypical ketosis-prone diabetes at 4 years of diabetes duration.

    Ramos-Román MA, Piñero-Piloña A, Adams-Huet B, Raskin P.

    J Diabetes Complications. 2006 May-Jun;20(3):137-44.PMID: 16632232 [PubMed - indexed for MEDLINE]Related articles

    42.

    Can glycemic targets be achieved-- in particular with two daily injections of a mix of intermediate- and short-acting insulin?

    Raskin P.

    Endocr Pract. 2006 Jan-Feb;12 Suppl 1:52-4. Review.PMID: 16627381 [PubMed - indexed for MEDLINE]Related articles

    43.

    Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

    Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

    Clin Ther. 2005;27 Suppl B:S57-74. Review.PMID: 16519038 [PubMed - indexed for MEDLINE]Related articles

    44.

    Hepatitis C infection and diabetes.

    Noto H, Raskin P.

    J Diabetes Complications. 2006 Mar-Apr;20(2):113-20. Review.PMID: 16504840 [PubMed - indexed for MEDLINE]Related articles

    45.

    Anthropometric features and cardiovascular risk in young Latin Americans with type 2 diabetes mellitus.

    Avilés-Santa L, Salinas K, Adams-Huet B, Raskin P.

    J Diabetes Complications. 2006 Mar-Apr;20(2):69-74.PMID: 16504834 [PubMed - indexed for MEDLINE]Related articles

    46.

    Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus.

    Avilés-Santa L, Salinas K, Adams-Huet B, Raskin P.

    J Investig Med. 2006 Jan;54(1):20-31.PMID: 16409887 [PubMed - indexed for MEDLINE]Related articles

    47.

    Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

    Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.

    N Engl J Med. 2005 Dec 22;353(25):2643-53.PMID: 16371630 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.

    Donofrio PD, Raskin P, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI; CAPSS-141 Study Group.

    Clin Ther. 2005 Sep;27(9):1420-31.PMID: 16291415 [PubMed - indexed for MEDLINE]Related articles

    49.

    Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.

    Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli F, Phillips RA, Raskin P, Wright JT Jr, Waterhouse B, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators.

    Hypertension. 2005 Dec;46(6):1309-15. Epub 2005 Nov 14.PMID: 16286578 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Initiation of insulin therapy in patients with type 2 diabetes failing oral therapy: response to Mikhail and Cope and to Janka.

    Raskin P.

    Diabetes Care. 2005 Nov;28(11):2811. No abstract available. PMID: 16249569 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...